Rational selection of the monoclonal α-synuclein antibody amlenetug (Lu AF82422) for the treatment of α-synucleinopathies.

Saved in:
Bibliographic Details
Title: Rational selection of the monoclonal α-synuclein antibody amlenetug (Lu AF82422) for the treatment of α-synucleinopathies.
Authors: Kallunki P; H. Lundbeck A/S, Research, Ottiliavej 9, 2500, Valby, Denmark. PEKA@Lundbeck.com., Sotty F; H. Lundbeck A/S, Research, Ottiliavej 9, 2500, Valby, Denmark., Willén K; H. Lundbeck A/S, Research, Ottiliavej 9, 2500, Valby, Denmark., Lubas M; H. Lundbeck A/S, Research, Ottiliavej 9, 2500, Valby, Denmark., David L; H. Lundbeck A/S, Research, Ottiliavej 9, 2500, Valby, Denmark., Ambjørn M; H. Lundbeck A/S, Research, Ottiliavej 9, 2500, Valby, Denmark., Bergström AL; H. Lundbeck A/S, Research, Ottiliavej 9, 2500, Valby, Denmark., Buur L; H. Lundbeck A/S, Research, Ottiliavej 9, 2500, Valby, Denmark., Malik I; H. Lundbeck A/S, Research, Ottiliavej 9, 2500, Valby, Denmark., Nyegaard S; H. Lundbeck A/S, Research, Ottiliavej 9, 2500, Valby, Denmark., Eriksen TT; H. Lundbeck A/S, Research, Ottiliavej 9, 2500, Valby, Denmark., Krogh BO; H. Lundbeck A/S, Research, Ottiliavej 9, 2500, Valby, Denmark., Stavenhagen JB; H. Lundbeck A/S, Research, Ottiliavej 9, 2500, Valby, Denmark., Andersen KJ; H. Lundbeck A/S, Research, Ottiliavej 9, 2500, Valby, Denmark., Pedersen LØ; H. Lundbeck A/S, Research, Ottiliavej 9, 2500, Valby, Denmark., Cholak E; H. Lundbeck A/S, Research, Ottiliavej 9, 2500, Valby, Denmark., van den Brink EN; Genmab, Uppsalalaan 15, 3584 CT, Utrecht, The Netherlands., Rademaker R; Genmab, Uppsalalaan 15, 3584 CT, Utrecht, The Netherlands., Vink T; Genmab, Uppsalalaan 15, 3584 CT, Utrecht, The Netherlands., Satijn D; Genmab, Uppsalalaan 15, 3584 CT, Utrecht, The Netherlands., Parren PWHI; Genmab, Uppsalalaan 15, 3584 CT, Utrecht, The Netherlands., Christensen S; H. Lundbeck A/S, Research, Ottiliavej 9, 2500, Valby, Denmark., Olsen LR; H. Lundbeck A/S, Research, Ottiliavej 9, 2500, Valby, Denmark., Søderberg JN; H. Lundbeck A/S, Research, Ottiliavej 9, 2500, Valby, Denmark., Vergo S; H. Lundbeck A/S, Research, Ottiliavej 9, 2500, Valby, Denmark., Jensen A; H. Lundbeck A/S, Research, Ottiliavej 9, 2500, Valby, Denmark., Egebjerg J; H. Lundbeck A/S, Research, Ottiliavej 9, 2500, Valby, Denmark., Wulff-Larsen PG; H. Lundbeck A/S, Research, Ottiliavej 9, 2500, Valby, Denmark., Harndahl MN; H. Lundbeck A/S, Research, Ottiliavej 9, 2500, Valby, Denmark., Damlund DSM; H. Lundbeck A/S, Research, Ottiliavej 9, 2500, Valby, Denmark., Bjerregaard-Andersen K; H. Lundbeck A/S, Research, Ottiliavej 9, 2500, Valby, Denmark., Fog K; H. Lundbeck A/S, Research, Ottiliavej 9, 2500, Valby, Denmark.
Source: NPJ Parkinson's disease [NPJ Parkinsons Dis] 2025 May 22; Vol. 11 (1), pp. 132. Date of Electronic Publication: 2025 May 22.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 101675390 Publication Model: Electronic Cited Medium: Print ISSN: 2373-8057 (Print) Linking ISSN: 23738057 NLM ISO Abbreviation: NPJ Parkinsons Dis Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2373-8057
DOI:10.1038/s41531-024-00849-1